| |
|
|
|
Sutro Biopharma Inc.  
|
|
9.02 0.29 (0.03%) |
07-10 16:00 |
|
Open: |
8.76 |
Pre close: |
8.73 |
Target:
|
12.02
|
|
High: |
9.26 |
Low: |
8.76 |
Resistance:
|
10.29
12.02
|
|
Volume: |
181,338 |
Market Cap: |
324M |
Support:
|
8.29
7.06
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.59
 |
MACD |
MACD(12,26):
|
-0.27 |
|
MA(20): |
8.65 |
Signal(12,26,9): |
-0.37 |
|
MA(100): |
9.45  |
Stochastic Oscillator |
%K(14,3):
|
52.53 |
|
MA(250): |
10.02 |
%D(3): |
46.61 |
|
Average Volume(K) |
3-Month: |
15920
|
52-Week |
High:
|
12.75 |
|
10-Days: |
29685 |
Low: |
6.00 |
|
RSI |
RSI(14):
|
52.78 |
Change(%): |
-21.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.650 |
Return on Equity (ttm) |
-57.4 |
Shares Out. (M) |
35.88 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-21.3 |
Shares Float (M) |
14.84 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
21.16 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-17.1 |
% Held by Institutions |
69.52 |
|
Forward EPS |
-2.430 |
Gross Profit (p.s.) |
-0.638 |
Shares Short (K) |
129 |
|
Book Value (p.s.) |
3.530 |
EBITDA (p.s.) |
-1.560 |
P/E |
-3.40 |
|
Sales Per Share |
1.150 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.56 |
|
Profit Margin |
-148.06 |
Operating Cash Flow
(M) |
-63.61 |
P/S |
7.84 |
|
Operating Margin |
-147.18 |
Levered Free Cash Flow
(M) |
-27.63 |
P/CF |
-5.09 |
|
|
|
|
|
|
